Array Technologies Builds a Plant Into a Solar Downturn — Here's What the Record Backlog Says

Array Technologies (NASDAQ: ARRY) did not pick an easy week to celebrate. On Wednesday the Albuquerque-based tracker maker cut the ribbon on a new, more than $50 million manufacturing plant on the city's West Side — just as its stock hovers near a 52-week low, down roughly 51% for the year, with the whole solar complex selling off in tandem. At face value it looks like a company pouring concrete into a crater.

The popular take is easy: a struggling market does not need new capacity. But that framing treats the plant as speculative supply built on hope. Array's own order book tells a more specific story, and separating the two matters before a beginner dismisses either the stock or the expansion.

What Array actually opened

The new facility spans 216,000 square feet, about three times the size of its previous Albuquerque site, and is expected to support roughly 300 jobs. The more consequential detail is what makes it more than just a bigger version of the old plant: Array says the expansion brings components previously bought from outside suppliers in-house, cutting delivery times and tightening supply-chain control. Several parts made there qualify for the Section 45X domestic manufacturing production tax credit.

That credit matters because the "volatile solar market" in the headline is not purely a demand story. Array's own risk disclosures tie that volatility to tariffs and trade policy, threatened cuts to renewable incentives, and interest rates that govern how utility-scale projects get financed. A plant that makes more of the product in the United States and earns a per-unit federal credit for doing so is, in part, a hedge against exactly the policy swings knocking down the sector's valuations.

The demand test contradicts the "weak market" read

The cleaner test of whether this is capacity built into weakness is the order book. As of the end of June, Array reported a record $2.5 billion of executed contracts and awarded orders — up 37% from a year earlier and its third straight record — with more than $500 million of new orders booked in the second quarter alone and a trailing-twelve-month book-to-bill ratio of 1.5x. A book-to-bill above one means Array booked half again as much business as it shipped over that stretch; at 1.5x it is largely selling more than it can deliver. That is presumably why management raised its full-year profit guidance in August rather than cutting it.

That is the mechanism that makes the concrete rational. You do not build a three-times-bigger plant to fill slots nobody has committed to. The expansion is timed to demand that is already booked, not to hope.

The parts that should keep you honest

None of this removes the reasons the stock fell. Revenue and reported earnings have declined year over year in recent quarters — second-quarter sales came in at $342 million versus $362 million a year earlier, and heavy preferred-share dividends pushed net income attributable to common shareholders down sharply. That GAAP softness, plus genuine policy and interest-rate uncertainty, is the fair share of the bear case; the stock is not a pure mispricing.

The offset is how much of that fear is now priced in. Array trades at roughly 0.6x sales while Nextracker sits near 3.4x and First Solar above 4x. It pays no dividend, so the "cash returned to shareholders" test does not apply the way it would to a mature cash generator; instead the relevant gate is free cash flow, which Array generated at about $135 million over the trailing year against a balance sheet near 2.2x debt-to-equity with some $307 million in cash. The $50 million plant is a real commitment relative to that cash generation.

Where that leaves a buyer, the cheap multiple and the expansion only pay off if the record backlog converts into revenue at the projected margins. The condition that would break the thesis is precisely that conversion: order cancellations, or a policy shift that strips the 45X credit and re-exposes the now-bigger plant to import competition. The whole case rests on whether already-booked demand actually materializes — which is a different, far more grounded question than the crater the share price implies.